Biofrontera INC. (BFRIW) — 10-Q Filings

All 10-Q filings from Biofrontera INC.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

Biofrontera's Losses Widen Amid Strategic Shift, Liquidity Concerns — Nov 12, 2025 Risk: high
Biofrontera Inc. reported a net loss of $6.649 million for the three months ended September 30, 2025, an increase from $5.669 million in the prior-year period.
Biofrontera Inc. Files Q1 2025 10-Q — May 15, 2025 Risk: medium
Biofrontera Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations for the first quarter of
Biofrontera Inc. Files Q3 2024 10-Q Report — Nov 14, 2024 Risk: medium
Biofrontera Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal year. Key
Biofrontera Inc. Files 10-Q for Q2 2024 — Aug 14, 2024 Risk: medium
Biofrontera Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of
Biofrontera Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk:
Biofrontera Inc. (BFRIW) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Biofrontera Inc. filed a 10-Q report for the quarterly period ended March

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX